US Patent Issued to VerImmune on Jan. 20 for "Conjugated virus-like particles and uses thereof as anti-tumor immune redirectors" (American, Thai Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,839, issued on Jan. 20, was assigned to VerImmune Inc. (Washington).

"Conjugated virus-like particles and uses thereof as anti-tumor immune redirectors" was invented by Joshua Weiyuan Wang (Alexandria, Va.), Nattha Ingavat (Bangkok) and Ken Matsui (Frederick, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a new class of conjugated virus-like particles (VLPs). These conjugated VLPs bind a wide variety of tumors and comprise epitopes recognized by a prior T cell immune response already existing in a host. These epitopes are derived from pathogens or previous vaccinations (such as early childhood vaccines). This provokes the body's pre...